Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):
Earnings: $0.74 million in Q4 vs. $1.40 million in the same period last year.
EPS: $0.00 in Q4 vs. $0.01 in the same period last year.
Analysts projected -$0.03 per share
Revenue: $35.79 million in Q4 vs. $51.28 million in the same period last year.
For comments and feedback: editorial@rttnews.com